Cardiology Department, State University of New York at Buffalo, USA.
Ann Acad Med Singap. 2010 Dec;39(12):927-7.
Primary percutaneous coronary intervention and thrombolysis remain therapies of choice for patients presenting with ST-segment elevation myocardial infarction (STEMI). Clinical outcome in the management of acute STEMI is dependent on myocardial reperfusion time and reperfusion strategies. Optimisation of these strategies should take into consideration logistical limitations of the local medical systems and the various patient profiles. We review the reperfusion strategies and its history in Singapore, comparing its clinical application with that in some developed Western countries.
对于出现 ST 段抬高型心肌梗死（STEMI）的患者，经皮冠状动脉介入治疗和溶栓治疗仍然是首选的治疗方法。急性 STEMI 管理的临床结果取决于心肌再灌注时间和再灌注策略。优化这些策略应考虑到当地医疗系统的后勤限制和各种患者特征。我们回顾了新加坡的再灌注策略及其历史，将其临床应用与一些发达国家进行了比较。
